Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease



Status:Completed
Conditions:Insomnia Sleep Studies, Parkinsons Disease
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:50 - 80
Updated:10/4/2017
Start Date:May 2015
End Date:June 2017

Use our guide to learn which trials are right for you!

Effects of Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease

Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a
diverse and growing list of disorders including cardiovascular disease. During WBPA, patients
lie in the supine position on a bed that is capable of translating back and forth parallel to
the ground, along the head-to-foot axis of the patient. Thus, this treatment is best
described as a form of "passive exercise." The frequency of the translation (up to 180
cycles/minute; cpm) as well as the distance traveled (2-24mm) by the bed can be adjusted by
the patient or health care professional.

The science behind the therapeutic effects of WBPA still remains largely unknown.

The investigators are observing how WBPA may impact on sleep and activity in individuals with
Parkinson's disease.

Sleep disturbances are common in individuals with Parkinson's Disease. Whole-body periodic
acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing
list of disorders. During WBPA, patients lie in the supine position on a bed that is capable
of translating back and forth parallel to the ground, along the head-to-foot axis of the
patient. Thus, this treatment is best described as a form of "passive exercise." WBPA has
been shown in previous studies to increase nitric oxide. Increased levels of nitric oxide
have been shown to improve sleep patterns in other populations. The current pilot study will
investigate how WBPA will impact upon sleep disturbances in subjects with Parkinson's disease
who suffer from abnormal sleep patterns. The investigators will record sleep patterns and
activity levels using a Jawbone U3® activity monitor.

Inclusion Criteria:

- Healthy individuals between the ages of 50-80

- Individuals with Parkinsons disease between the ages of 50-80

- Individuals with a smart phone

Exclusion Criteria:

- Any condition that prevents you from lying flat on your back, any other neurological
condition than Parkinson's disease.
We found this trial at
1
site
Old Westbury, New York 11568
?
mi
from
Old Westbury, NY
Click here to add this to my saved trials